These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 17194266

  • 1. Treatment with rosuvastatin for severe dyslipidemia in patients with schizophrenia and schizoaffective disorder.
    De Hert M, Kalnicka D, van Winkel R, Wampers M, Hanssens L, Van Eyck D, Scheen A, Peuskens J.
    J Clin Psychiatry; 2006 Dec; 67(12):1889-96. PubMed ID: 17194266
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Pharmacological treatment of severe dyslipidaemia in patients with schizophrenia.
    Hanssens L, De Hert M, Kalnicka D, van Winkel R, Wampers M, Van Eyck D, Scheen A, Peuskens J.
    Int Clin Psychopharmacol; 2007 Jan; 22(1):43-9. PubMed ID: 17159459
    [Abstract] [Full Text] [Related]

  • 4. One-year efficacy and safety of rosuvastatin + fenofibric acid combination therapy in patients with mixed dyslipidemia: evaluation of dose response.
    Ferdinand KC, Davidson MH, Kelly MT, Setze CM.
    Am J Cardiovasc Drugs; 2012 Apr 01; 12(2):117-25. PubMed ID: 22263674
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Efficacy of rosuvastatin 10 mg in patients with the metabolic syndrome.
    Ballantyne CM, Stein EA, Paoletti R, Southworth H, Blasetto JW.
    Am J Cardiol; 2003 Mar 06; 91(5A):25C-27C; discussion 28C. PubMed ID: 12646342
    [Abstract] [Full Text] [Related]

  • 13. The DISCOVERY PENTA study: a DIrect Statin COmparison of LDL-C Value--an Evaluation of Rosuvastatin therapY compared with atorvastatin.
    Fonseca FA, Ruiz A, Cardona-Muñoz EG, Silva JM, Fuenmayor N, Marotti M, DISCOVERY PENTA investigators.
    Curr Med Res Opin; 2005 Aug 06; 21(8):1307-15. PubMed ID: 16083541
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of rosuvastatin in treatment of dyslipidemia.
    McKenney JM.
    Am J Health Syst Pharm; 2005 May 15; 62(10):1033-47. PubMed ID: 15901588
    [Abstract] [Full Text] [Related]

  • 17. Are HIV positive patients resistant to statin therapy?
    Johns KW, Bennett MT, Bondy GP.
    Lipids Health Dis; 2007 Oct 24; 6():27. PubMed ID: 17958912
    [Abstract] [Full Text] [Related]

  • 18. Comparison of atorvastatin, pitavastatin and rosuvastatin for residual cardiovascular risk using non-fasting blood sampling.
    Kakuda H, Matoba M, Nakatoh H, Nagao S, Takekoshi N.
    Scand J Clin Lab Invest; 2014 Jun 24; 74(4):285-95. PubMed ID: 24564634
    [Abstract] [Full Text] [Related]

  • 19. Achievement rates of Japan Atherosclerosis Society Guidelines 2007 LDL-cholesterol goals with rosuvastatin or atorvastatin in patients who had not achieved their goal with atorvastatin.
    Shioji K, Izuhara M, Mitsuoka H, Uegaito T, Matsuda M, Kishiwada Atherosclerosis Prevention Study (KAPS) Group.
    Cardiovasc Ther; 2014 Jun 24; 32(3):97-104. PubMed ID: 24456217
    [Abstract] [Full Text] [Related]

  • 20. Daily and intermittent rosuvastatin 5 mg therapy in statin intolerant patients: an observational study.
    Meek C, Wierzbicki AS, Jewkes C, Twomey PJ, Crook MA, Jones A, Viljoen A.
    Curr Med Res Opin; 2012 Mar 24; 28(3):371-8. PubMed ID: 22256801
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.